Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk Patients

NARecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Spinal DeformityTraumaSpinal TumorSurgical Site Infection
Interventions
DRUG

Vancomycin powder

For the intervention group, the use of 1g vancomycin powder to be placed in the deep wound and subcutaneous layer prior to closure.

Trial Locations (1)

Unknown

RECRUITING

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER